Medical Communications
GSK settles first Zantac lawsuit due for trial in US
June 23, 2023 Medical Communications Cancer, GSK, Pharmacy, Zantac, lawsuit
FDA approves new medicines to treat paediatric type 2 diabetes
June 22, 2023 Medical Communications Diabetes, FDA, Synjardy, jardiance, paediatrics, type 2 diabetes
FDA approves Pfizer’s HRR mCRPC drug
June 21, 2023 Medical Communications FDA, Oncology, Pfizer, breast cancer, oncology, prostate cancer
PharmaTher and Vitruvias sign collaboration agreement to commercialise ketamine-based treatment in the US
June 21, 2023 Medical Communications Ketamine, Neurology, PharmaTher, Vitruvias, commercialisation
Abu Dhabi’s Department of Health, M42 and AbbVie enter strategic partnership
June 20, 2023 Medical Communications AbbVie, Abu Dhabi, DoH, M42, Oncology, strategic partnership
GSK announces extension of FDA’s review for momelotinib
June 20, 2023 Medical Communications FDA, GSK, Oncology, momelotinib, new drug application
Santhera and Catalyst Pharmaceuticals sign $231m license and collaboration deal
June 20, 2023 Medical Communications Catalyst Pharmaceuticals, Rare Diseases, Vamorolone, licence and collaboration, santhera
Rani Therapeutics’ oral ‘robotic pill’ delivers injection trans-enterically
June 19, 2023 Medical Communications Osteoporosis, Rani Therapeutics, injection, osteoporosis, robotic pill, robotics
Inventiva and Echosens collaborate to bring awareness to NASH and encourage screening for at-risk patients
June 8, 2023 Medical Education Echosens, Hepatology, Inventiva, liver disease, nash, non-alcoholic steatohepatitis
GSK’s RSV vaccine approved in EU for older adults
June 7, 2023 Medical Communications EU, GSK, Infections and infestations, RSV, Vaccine
Bellerophon shares top-line data from phase 3 trial of INOpulse for fILD
June 6, 2023 Medical Communications Bellerophon Therapeutics, Cardiology, clinical trials, fibrotic interstitial lung disease
Quanticate announces strategic partnership with KPS Life
June 5, 2023 Medical Communications KPS Life, Pharmacy, Quanticate, fsp
NICE approves first treatment for obstructive HCM for NHS use
June 2, 2023 Medical Communications Bristol-Myers Squibb, Cardiology, NHS, NICE, obstructive HCM
NICE recommends Pfizer’s rimegepant for preventing episodic migraine attacks
June 2, 2023 Medical Communications NHS, NICE, Neurology, Pfizer, migraine
European Parliament shares goal to tackle antimicrobial resistance
June 2, 2023 Medical Communications EU, European Parliament, Microbiology, antimicrobial resistance
Latest content
